CLGN
NASDAQ
$0.32
CollPlant Biotechnologies Ltd New (CLGN)
CollPlant Biotechnologies Ltd., an aesthetic and regenerative medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. The company is headquartered in Rehovot, Israel.
Sector:
Healthcare
Industry:
Biotechnology
Target: $11.12 (+3353.42%)
Market Cap
$4.80M
Beta (5Y)
0.55
Price Chart
Valuation
Market Cap$4.80M
Forward P/E80.00
P/S16.50
P/B1.30
Profitability
Total Revenue (TTM)$389K
Gross Profit (TTM)-$574K
EBITDA-$12M
Operating Margin-4267%
EPS-$1.03
Financial Health
Debt-to-Equity54.2%
Growth & Risk
Revenue 5Y CAGR-54.54%
Beta (5Y)0.55
Sharpe Ratio-0.91